18
Participants
Start Date
January 5, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
UCMSC
Each infusion will consist of 1 million MSC/kg suspended in 50 mL of PlasmaLyte A.
Placebo
Each infusion will consist of 50 mL of PlasmaLyte A.
RECRUITING
Sir Mortimer B. Davis Jewish General Hospital, Montreal
Medical University of South Carolina
OTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Université de Montréal
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER
University Paris 7 - Denis Diderot
OTHER
Marie Hudson, MD
OTHER